“…In particular, white matter microstructural changes including focal tissue damage (lesions) and alterations to normal‐appearing white matter occur in youth with MS and monophasic demyelinating disorders (Amato et al, ; Amato, Krupp, Charvet, Penner, & Till, ; Aubert‐Broche et al, , ; Longoni et al, ). DTI has been used extensively in children and adolescents with acquired demyelinating disorders to demonstrate tissue abnormality in normal‐appearing white matter (Akbar et al, ; Aliotta et al, ; Aung et al, ; Longoni et al, ; Rocca et al, ; Till et al, ; Tillman, Leach, & Pirko, ; Vishwas et al, ; Vishwas, Chitnis, Pienaar, Healy, & Grant, ).…”